Chongqing Genrix Biopharmaceutical Co (SHSE:688443) Forward Dividend Yield %: 0.00% (As of Jul. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688443 Chongqing Genrix Biopharmaceutical Co Ltd SHSE:688443
43 GF Score
Price ¥25.03
! 4 Warning Signs
View Full Analysis

What is Chongqing Genrix Biopharmaceutical Co Forward Dividend Yield %?

Chongqing Genrix Biopharmaceutical Co SHSE:688443 +0.81% 43 Forward Dividend Yield % is 0.00% as of Jul. 21, 2026. GuruFocus rates SHSE:688443 with a GF Score™ of 43/100. The stock has 4 warning signs investors should review. Among 149 Biotechnology companies, Chongqing Genrix Biopharmaceutical Co ranks worse than 671140.27% on this metric.

As of today (2026-07-21), the Forward Annual Dividend Yield of Chongqing Genrix Biopharmaceutical Co is 0.00%.

As of today (2026-07-21), the Trailing Annual Dividend Yield of Chongqing Genrix Biopharmaceutical Co is 0.00%.

SHSE:688443's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.36
* Ranked among companies with meaningful Forward Dividend Yield % only.

Chongqing Genrix Biopharmaceutical Co's Dividends per Share for the three months ended in Mar. 2026 was ¥0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Chongqing Genrix Biopharmaceutical Co  (SHSE:688443) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Chongqing Genrix Biopharmaceutical Co Forward Dividend Yield % Related Terms

SHSE:688443 vs VRTX, REGN, ALNY: Forward Dividend Yield % Comparison

For the Biotechnology subindustry, Chongqing Genrix Biopharmaceutical Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chongqing Genrix Biopharmaceutical Co Forward Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chongqing Genrix Biopharmaceutical Co's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Chongqing Genrix Biopharmaceutical Co's Forward Dividend Yield % falls into.


SHSE:688443
43GF Score
Chongqing Genrix Biopharmaceutical Co Ltd SHSE:688443
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chongqing Genrix Biopharmaceutical Co Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Chongqing Genrix Biopharmaceutical Co (SHSE:688443) has a Forward Dividend Yield % of 0.00% as of Jul. 21, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Chongqing Genrix Biopharmaceutical Co and its competitors. According to the industry distribution chart, Chongqing Genrix Biopharmaceutical Co ranks #999999 out of 149 companies in the Biotechnology industry.
Is Chongqing Genrix Biopharmaceutical Co's Forward Dividend Yield % too high?
Chongqing Genrix Biopharmaceutical Co's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Chongqing Genrix Biopharmaceutical Co ranks #999999 out of 149 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Chongqing Genrix Biopharmaceutical Co has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Chongqing Genrix Biopharmaceutical Co's Forward Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Chongqing Genrix Biopharmaceutical Co ranks #999999 out of 149 companies for Forward Dividend Yield %. This places Chongqing Genrix Biopharmaceutical Co in the lower half of its industry. The industry median Forward Dividend Yield % is 1.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.36, based on 149 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Chongqing Genrix Biopharmaceutical Co and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chongqing Genrix Biopharmaceutical Co's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chongqing Genrix Biopharmaceutical Co stock overvalued right now?
Chongqing Genrix Biopharmaceutical Co (SHSE:688443) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. Chongqing Genrix Biopharmaceutical Co's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Chongqing Genrix Biopharmaceutical Co (SHSE:688443), the current Forward Dividend Yield % is 0.00% as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chongqing Genrix Biopharmaceutical Co Business Description

Address No. 699, Maliu Avenue, Area A, Building 2, International Bio City, Banan District, Chongqing, CHN, 401338
Chongqing Genrix Biopharmaceutical Co Ltd is a biopharmaceutical company engaged in the research & development, production and sales of antibody drugs. The company's pipeline includes product candidate that targets Autoimmune Diseases, Infectious Diseases, and Oncology.
43GF Score

Get the complete analysis for SHSE:688443

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥25.03
Price